mafenide has been researched along with Opportunistic Infections in 1 studies
Mafenide: A sulfonamide that inhibits the enzyme CARBONIC ANHYDRASE and is used as a topical anti-bacterial agent, especially in burn therapy.
Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wright, JB | 1 |
| Lam, K | 1 |
| Hansen, D | 1 |
| Burrell, RE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open, Non-comparative, Multicentre, Interventional Post-market Clinical Follow-up (PMCF) Study to Evaluate the Performance and Safety of the Medical Device Argogen® (Adsorbing Spray Powder for Exudates With Silver Ions) in the Treatment of Pressure Ulcers[NCT05649332] | 68 participants (Anticipated) | Interventional | 2023-05-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for mafenide and Opportunistic Infections
| Article | Year |
|---|---|
Efficacy of topical silver against fungal burn wound pathogens.
Topics: Antifungal Agents; Aspergillus fumigatus; Bandages; Burns; Candida; Colony Count, Microbial; Dermato | 1999 |